Amalgamated Financial Corp.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Amalgamated Financial Corp. reported net income of $104.4M (-1.9% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Loans | $240.6M | $215.4M | $191.3M | $145.6M |
| Securities | $176.3M | $177.2M | $161.0M | $110.7M |
| Interest-bearing deposits in banks | $5.3M | $8.7M | $5.8M | $2.2M |
| Total interest and dividend income | $422.2M | $401.3M | $358.1M | $258.5M |
| Deposits | $121.6M | $113.5M | $81.1M | $11.1M |
| Borrowed funds | $2.9M | $5.4M | $15.6M | $7.6M |
| Total interest expense | $124.4M | $118.9M | $96.8M | $18.6M |
| NET INTEREST INCOME | $297.8M | $282.4M | $261.3M | $239.8M |
| Provision for credit losses | $16.3M | $10.3M | $14.7M | — |
| Net interest income after provision for credit losses | $281.5M | $272.1M | $246.6M | $224.8M |
| Trust Department fees | $16.2M | $15.2M | $15.2M | $14.4M |
| Service charges on deposit accounts | $17.5M | $32.2M | $11.0M | $11.0M |
| Bank-owned life insurance income | $3.1M | $2.5M | $2.9M | $3.9M |
| Losses on sale of securities and other assets, net | ($3.4M) | ($9.7M) | ($7.4M) | ($3.6M) |
| Gain (loss) on sale of loans and changes in fair value on loans held-for-sale, net | ($2.7M) | ($8.2M) | $32.0K | ($610.0K) |
| Equity method investments income (loss) | ($1.7M) | ($831.0K) | $4.9M | ($2.8M) |
| Other income | $2.0M | $2.1M | $2.7M | $1.8M |
| Total non-interest income | $30.9M | $33.2M | $29.3M | $23.9M |
| Compensation and employee benefits | $98.6M | $93.8M | $85.8M | $74.7M |
| Occupancy and depreciation | $13.4M | $13.1M | $13.6M | $13.7M |
| Professional fees | $14.3M | $10.0M | $9.6M | $10.4M |
| Technology | $24.1M | $19.8M | $17.7M | $17.7M |
| Office maintenance and depreciation | $2.1M | $2.5M | $2.8M | $3.0M |
| Amortization of intangible assets | $574.0K | $730.2K | $888.0K | $1.0M |
| Advertising and promotion | $2.4M | $3.7M | $4.2M | $3.7M |
| Federal deposit insurance premiums | $3.8M | $3.7M | $4.0M | $3.2M |
| Other expense | $13.1M | $12.5M | $12.6M | $13.0M |
| Total non-interest expense | $172.2M | $159.8M | $151.2M | $140.6M |
| Income before income taxes | $140.2M | $145.6M | $124.7M | $108.2M |
| Income tax expense | $35.7M | $39.2M | $36.8M | $26.7M |
| Net income | $104.4M | $106.4M | $88.0M | $81.5M |
| Earnings per common share - basic (in dollars per share) | $3.44 | $3.48 | $2.88 | $2.64 |
| Earnings per common share - diluted (in dollars per share) | $3.41 | $3.44 | $2.86 | $2.61 |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Loans | $66.0M | $63.5M | $62.3M | $58.7M |
| Securities | $49.6M | $44.2M | $46.0M | $43.7M |
| Interest-bearing deposits in banks | $1.6M | $1.7M | $1.2M | $1.6M |
| Total interest and dividend income | $117.2M | $109.3M | $109.6M | $104.1M |
| Deposits | $30.6M | $28.6M | $32.6M | $30.6M |
| Borrowed funds | $543.0K | $543.0K | $555.0K | $597.0K |
| Total interest expense | $31.1M | $29.2M | $33.1M | $31.2M |
| NET INTEREST INCOME | $86.1M | $80.2M | $76.4M | $72.9M |
| Provision for credit losses | $4.4M | $13.5M | $5.3M | $4.9M |
| Net interest income after provision for credit losses | $81.6M | $66.7M | $71.1M | $68.0M |
| Trust Department fees | $4.2M | $4.3M | $4.0M | $3.9M |
| Service charges on deposit accounts | $6.9M | $7.2M | $4.3M | $3.9M |
| Bank-owned life insurance income | $648.0K | $1.3M | $1.1M | $796.0K |
| Losses on sale of securities and other assets, net | ($39.0K) | ($822.0K) | ($1.2M) | ($1.0M) |
| Gain on sale of loans and changes in fair value on loans held-for-sale, net | $0 | $12.0K | $70.0K | $18.0K |
| Equity method investments income (loss) | $227.0K | $624.0K | $597.0K | $51.0K |
| Other income | $373.0K | $640.0K | $440.0K | $449.0K |
| Total non-interest income | $12.3M | $13.3M | $9.2M | $8.0M |
| Compensation and employee benefits | $27.2M | $25.8M | $25.5M | $23.2M |
| Occupancy and depreciation | $3.5M | $4.2M | $3.5M | $3.5M |
| Professional fees | $3.0M | $3.7M | $3.4M | $3.3M |
| Technology | $7.4M | $6.6M | $6.0M | $5.5M |
| Office maintenance and depreciation | $484.0K | $550.0K | $582.0K | $570.0K |
| Amortization of intangible assets | $105.0K | $105.0K | $144.0K | $144.0K |
| Advertising and promotion | $900.0K | $605.0K | $497.0K | $412.0K |
| Federal deposit insurance premiums | $1.0M | $1.0M | $1.0M | $900.0K |
| Other expense | $3.7M | $3.4M | $3.1M | $3.1M |
| Total non-interest expense | $47.3M | $45.9M | $43.6M | $40.6M |
| Income before income taxes | $46.6M | $34.1M | $36.7M | $35.5M |
| Income tax expense | $11.9M | $8.8M | $9.9M | $9.5M |
| Net income | $34.8M | $25.2M | $26.8M | $26.0M |
| Earnings per common share - basic (in dollars per share) | $1.16 | $0.85 | $0.89 | $0.85 |
| Earnings per common share - diluted (in dollars per share) | $1.15 | $0.84 | $0.88 | $0.84 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and due from banks | $4.5M | $4.0M | $2.9M | $5.1M |
| Interest-bearing deposits in banks | $286.7M | $56.7M | $87.7M | $58.4M |
| Total cash and cash equivalents | $291.2M | $60.7M | $90.6M | $63.5M |
| Available for sale, at fair value | $1.8B | $1.6B | $1.5B | $1.8B |
| Held-to-maturity, at amortized cost | $1.6B | $1.6B | $1.7B | — |
| Loans held for sale | $2.8M | $37.6M | $1.8M | $7.9M |
| Loans receivable, net of deferred loan origination fees and costs | $5.0B | $4.7B | $4.4B | $4.1B |
| Allowance for credit losses | ($57.6M) | ($60.1M) | ($65.7M) | ($45.0M) |
| Loans receivable, net | $4.9B | $4.6B | $4.3B | $4.1B |
| Resell agreements | $48.7M | $23.7M | $50.0M | $25.8M |
| Federal Home Loan Bank of New York ("FHLBNY") stock, at cost | $5.0M | $15.7M | $4.4M | $29.6M |
| Accrued interest receivable | $65.1M | $61.2M | $55.5M | $41.4M |
| Premises and equipment, net | $4.7M | $6.4M | $7.8M | $9.9M |
| Bank-owned life insurance | $108.9M | $108.0M | $105.5M | $105.6M |
| Right-of-use lease asset | $9.6M | $14.2M | $21.1M | $28.2M |
| Deferred tax asset, net | $30.8M | $42.4M | $56.6M | $62.5M |
| Goodwill | $12.9M | $12.9M | $12.9M | $12.9M |
| Intangible assets, net | $913.0K | $1.5M | $2.2M | $3.1M |
| Equity method investments | $8.0M | $8.5M | $13.0M | $8.3M |
| Other assets | $43.9M | $35.9M | $25.4M | $29.5M |
| Total assets | $8.9B | $8.3B | $8.0B | $7.8B |
| Deposits | $7.9B | $7.2B | $7.0B | $6.6B |
| Borrowings | $69.5M | $314.4M | $234.4M | — |
| Operating leases | $12.3M | $19.7M | $30.6M | $40.8M |
| Other liabilities | $44.3M | $34.5M | $39.4M | $40.6M |
| Total liabilities | $8.1B | $7.5B | $7.4B | $7.3B |
| Common stock, par value $0.01 per share (70,000,000 shares authorized; 31,045,377 and 30,809,484 shares issued, respectively, and 29,818,424 and 30,670,982 shares outstanding, respectively) | $312000.00 | $308000.00 | $307000.00 | $307000.00 |
| Additional paid-in capital | $294.1M | $288.7M | $288.2M | $286.9M |
| Retained earnings | $567.3M | $480.1M | $388.0M | $330.3M |
| Accumulated other comprehensive loss, net of income taxes | ($32.1M) | ($58.6M) | ($86.0M) | ($108.7M) |
| Treasury stock, at cost (1,226,953 and 138,502 shares, respectively) | -35.2M | -2.8M | -5.3M | — |
| Total stockholders' equity | $794.5M | $707.7M | $585.4M | $509.0M |
| Total liabilities and stockholders’ equity | $8.9B | $8.3B | $8.0B | $7.8B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Cash and due from banks | $4.2M | $11.6M | $5.0M | $4.0M |
| Interest-bearing deposits in banks | $163.6M | $168.1M | $110.5M | $167.0M |
| Total cash and cash equivalents | $167.8M | $179.7M | $115.5M | $171.1M |
| Available for sale, at fair value: | $2.2B | $2.1B | $2.0B | $1.9B |
| Held-to-maturity, at amortized cost | $1.6B | $1.5B | $1.5B | $1.6B |
| Loans held for sale | $459.0K | $459.0K | $2.6M | $2.5M |
| Loans receivable, net of deferred loan origination fees and costs | $5.1B | $5.0B | $4.8B | $4.7B |
| Allowance for credit losses | ($68.9M) | ($68.2M) | ($56.5M) | ($59.0M) |
| Loans receivable, net | $5.1B | $5.0B | $4.7B | $4.7B |
| Resell agreements | $59.3M | $66.1M | $59.0M | $57.0M |
| Federal Home Loan Bank of New York ("FHLBNY") stock, at cost | $5.2M | $5.0M | $5.3M | $5.3M |
| Accrued interest receivable | $63.8M | $56.2M | $57.1M | $55.5M |
| Premises and equipment, net | $20.2M | $10.1M | $6.2M | $8.8M |
| Bank-owned life insurance | $108.5M | $107.8M | $108.3M | $108.5M |
| Right-of-use lease asset | $7.6M | $9.4M | $11.5M | $11.4M |
| Deferred tax asset, net | $33.3M | $31.3M | $28.0M | $33.7M |
| Goodwill | $12.9M | $12.9M | $12.9M | $12.9M |
| Intangible assets, net | $704.0K | $808.0K | $1.1M | $1.2M |
| Equity method investments | $5.5M | $5.6M | $6.5M | $5.1M |
| Other assets | $33.8M | $29.0M | $39.6M | $35.0M |
| Total assets | $9.4B | $9.2B | $8.7B | $8.6B |
| Deposits | $8.5B | $8.2B | $7.8B | $7.7B |
| Borrowings | $69.8M | $69.6M | $75.5M | $75.5M |
| Operating leases | $9.1M | $11.5M | $14.8M | $15.4M |
| Other liabilities | $39.3M | $104.2M | $47.2M | $43.2M |
| Total liabilities | $8.6B | $8.4B | $7.9B | $7.9B |
| Common stock, par value $0.01 per share (70,000,000 shares authorized; 31,207,172 and 31,045,377 shares issued, respectively, and 29,900,147 and 29,818,424 shares outstanding, respectively) | $315000.00 | $315000.00 | $310000.00 | $310000.00 |
| Additional paid-in capital | $296.5M | $294.5M | $292.0M | $290.3M |
| Retained earnings | $616.9M | $587.3M | $544.9M | $522.4M |
| Accumulated other comprehensive loss, net of income taxes | ($40.8M) | ($36.6M) | ($35.2M) | ($43.0M) |
| Treasury stock, at cost (1,307,025 and 1,226,953 shares, respectively) | -37.9M | -37.9M | -26.4M | -16.0M |
| Total stockholders' equity | $835.0M | $807.6M | $775.6M | $754.0M |
| Total liabilities and stockholders’ equity | $9.4B | $9.2B | $8.7B | $8.6B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income | $104.4M | $106.4M | $88.0M | $81.5M |
| Depreciation and amortization | $6.2M | $4.7M | $3.5M | $3.5M |
| Amortization of intangible assets | $574.0K | $730.2K | $888.0K | $1.0M |
| Deferred income tax expense | $1.7M | $5.2M | $4.2M | $14.4M |
| Provision for credit losses | $16.3M | $10.3M | $14.7M | — |
| Stock-based compensation expense | $6.9M | $5.5M | $4.7M | $2.7M |
| Net (income) loss from equity method investments | $1.7M | $831.0K | ($4.9M) | $2.8M |
| Net loss on sale of securities available for sale and other assets | $3.4M | $9.7M | $7.4M | $3.6M |
| Net (gain) loss on sale of loans and change in fair value on loans held-for-sale | $2.7M | $8.2M | ($32.0K) | $610.0K |
| Net gain on death benefits of bank-owned life insurance | ($562.0K) | $0 | ($613.0K) | ($1.9M) |
| Net gain on repurchase of subordinated debt | $0 | ($1.1M) | ($1.4M) | ($617.0K) |
| Proceeds from sales of loans held for sale | $29.0M | $22.1M | $17.8M | $28.4M |
| Originations of loans held for sale | ($30.1M) | ($21.7M) | ($14.6M) | ($8.4M) |
| Increase in cash surrender value of bank-owned life insurance | ($2.6M) | ($2.5M) | ($2.3M) | ($2.0M) |
| Increase in accrued interest receivable | ($4.0M) | ($5.7M) | — | — |
| Decrease (increase) in other assets | ($856.0K) | ($2.4M) | $11.7M | $19.1M |
| Increase (decrease) in other liabilities | $778.0K | ($16.2M) | $181.0K | ($5.8M) |
| Net cash provided by operating activities | $135.8M | $124.1M | $117.2M | $147.3M |
| Net increase in loans | ($342.0M) | ($360.2M) | ($317.2M) | ($826.3M) |
| Proceeds from sales of loans | $73.2M | $36.6M | — | — |
| Purchase of securities available for sale | ($965.0M) | ($824.5M) | ($116.5M) | ($678.9M) |
| Purchase of securities held-to-maturity | ($158.0M) | ($92.2M) | ($264.5M) | ($584.9M) |
| Proceeds from sales of securities available for sale | $364.8M | $394.1M | $285.4M | $249.9M |
| Maturities, principal payments and redemptions of securities available for sale | $477.9M | $310.8M | $167.8M | $325.6M |
| Maturities, principal payments and redemptions of securities held-to-maturity | $190.9M | $204.3M | $108.9M | $139.3M |
| Decrease (increase) in resell agreements | ($24.9M) | $26.3M | ($24.2M) | $203.3M |
| Decrease (increase) in equity method investments | ($6.5M) | $1.9M | — | — |
| Decrease (increase) in FHLBNY stock, net | $10.7M | ($11.3M) | $25.2M | ($25.9M) |
| Purchases of premises and equipment, net | ($1.4M) | ($1.8M) | ($1.5M) | ($1.7M) |
| Proceeds from redemption of bank-owned life insurance | $2.2M | $0 | $2.9M | $4.2M |
| Proceeds from sale of owned assets | $46.0K | — | — | $0 |
| Net cash used in investing activities | ($378.0M) | ($315.9M) | ($134.4M) | ($1.2B) |
| Net increase in deposits | $768.6M | $168.6M | $417.0M | $238.8M |
| Increase (decrease) in other borrowings, net | ($244.9M) | $16.3M | ($345.6M) | — |
| Repurchase of subordinated debt | $0 | ($5.9M) | ($6.0M) | ($5.6M) |
| Common stock issued under Equity Program | $1.4M | $789.0K | $804.0K | — |
| Redemption of AREMCO class B shares | 0 | -152.0K | — | 0 |
| Repurchase of common stock | ($32.3M) | ($1.1M) | ($8.3M) | ($12.5M) |
| Dividends paid on common stock | ($17.2M) | ($14.2M) | ($12.3M) | ($11.2M) |
| Payments related to repurchase of common stock for equity awards | ($2.8M) | ($2.2M) | ($1.2M) | — |
| Net cash provided by financing activities | $472.7M | $162.1M | $44.2M | $788.2M |
| Increase (decrease) in cash, cash equivalents, and restricted cash | $230.5M | ($29.8M) | $27.0M | ($266.9M) |
| Cash, cash equivalents, and restricted cash at beginning of year | $60.7M | $90.6M | $63.5M | $330.5M |
| Cash, cash equivalents, and restricted cash at end of year | $291.2M | $60.7M | $90.6M | $63.5M |
| Interest paid during the year | $124.4M | $128.8M | $85.7M | $18.0M |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net income | $60.0M | $25.2M | $77.8M | $51.0M |
| Depreciation, amortization, and accretion, net | $1.0M | $2.0M | $717.0K | $609.0K |
| Amortization of intangible assets | $209.0K | $105.0K | $431.0K | $287.0K |
| Deferred income tax expense | $614.0K | $1.1M | $5.8M | $3.0M |
| Provision for credit losses | $17.9M | $13.5M | $10.8M | $5.5M |
| Stock-based compensation expense | $4.2M | $2.0M | $4.9M | $3.2M |
| Net (gain) loss from equity method investments | ($850.0K) | ($624.0K) | $1.9M | $2.5M |
| Net loss on sale of securities available for sale and other assets | $861.0K | $822.0K | $2.9M | $1.7M |
| Net gain on sale of loans and change in fair value on loans held-for-sale, net | ($12.0K) | ($12.0K) | ($920.0K) | ($850.0K) |
| Net gain on death benefits of bank-owned life insurance | ($681.0K) | ($681.0K) | ($562.0K) | ($160.0K) |
| Proceeds from sales of loans originated as held for sale | $1.7M | $1.7M | $20.6M | $9.2M |
| Originations of loans held for sale | ($458.0K) | ($458.0K) | ($22.1M) | ($10.6M) |
| Increase in cash surrender value of bank-owned life insurance | ($1.3M) | ($641.0K) | ($1.9M) | ($1.3M) |
| Decrease in accrued interest receivable | $1.3M | $8.9M | $4.1M | $5.7M |
| Decrease in other assets | $13.8M | $18.2M | $549.0K | $1.2M |
| Decrease in other liabilities | ($11.0M) | ($14.3M) | ($6.5M) | ($11.8M) |
| Net cash provided by operating activities | $87.3M | $56.8M | $98.6M | $59.1M |
| Net increase in loans | ($195.6M) | ($78.0M) | ($127.2M) | ($43.9M) |
| Proceeds from sales of loans originated as held for investment | $470.0K | $470.0K | $34.8M | $34.8M |
| Purchase of securities available for sale | ($794.7M) | ($437.6M) | ($761.2M) | ($473.3M) |
| Purchase of securities held-to-maturity | ($95.9M) | ($14.4M) | ($65.6M) | ($35.2M) |
| Proceeds from sales of securities available for sale | $135.2M | $46.2M | $120.2M | $56.1M |
| Maturities, principal payments and redemptions of securities available for sale | $192.2M | $96.6M | $328.6M | $189.2M |
| Maturities, principal payments and redemptions of securities held-to-maturity | $78.5M | $20.5M | $140.1M | $55.3M |
| Increase in resell agreements | ($10.6M) | ($17.5M) | ($35.2M) | ($33.3M) |
| Decrease in equity method investments | $1.2M | $920.0K | $94.0K | $914.0K |
| Decrease (increase) in FHLBNY stock, net | ($240.0K) | $0 | $10.4M | $10.4M |
| Purchase of premises and equipment, net | ($17.0M) | ($6.1M) | ($2.2M) | ($1.0M) |
| Proceeds from redemption of bank-owned life insurance | $1.5M | $1.5M | $983.0K | $983.0K |
| Proceeds from sale of owned assets | $0 | — | $46.0K | $46.0K |
| Net cash used in investing activities | ($705.1M) | ($387.4M) | ($356.0M) | ($239.0M) |
| Net increase in deposits | $509.2M | $228.8M | $589.4M | $552.7M |
| Net increase (decrease) in other borrowings | $164.0K | $0 | ($239.0M) | ($239.0M) |
| Common stock issued under Equity Programs | $1.0M | $750.0K | $1.2M | $1.0M |
| Repurchase of common stock | ($2.8M) | ($2.8M) | ($23.6M) | ($13.2M) |
| Dividends paid on common stock | ($10.4M) | ($5.3M) | ($13.0M) | ($8.8M) |
| Payments related to repurchase of common stock for equity awards | ($2.8M) | ($2.5M) | ($2.8M) | ($2.6M) |
| Net cash provided by financing activities | $494.4M | $219.1M | $312.2M | $290.2M |
| Increase (decrease) in cash, cash equivalents, and restricted cash | ($123.4M) | ($111.5M) | $54.8M | $110.3M |
| Cash, cash equivalents, and restricted cash at beginning of year | $291.2M | $291.2M | $60.7M | $60.7M |
| Cash, cash equivalents, and restricted cash at end of period | $167.8M | — | — | — |
| Interest paid during the period | $60.4M | $28.6M | $94.1M | $61.4M |
| Income taxes paid during the period | $20.9M | $20.9M | $20.9M | $14.8M |
| Right-of-use assets obtained in exchange for lease liabilities | $1.7M | $1.7M | $2.9M | $829.0K |
| Loans transferred to held-for-investment | $670.0K | $670.0K | $0 | $2.5M |
Amalgamated Financial Corp. score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.